Year: 2026
Type: article
Abstract: The heteromeric amino acid transporter y⁺LAT1/CD98hc (SLC7A7/SLC3A2) mediates electroneutral exchange of cationic and neutral amino acids, with Na⁺ required for efficient transport of neutral substrates. Loss-of-function mutations cause Lysinuric Protein Intolerance (LPI), and emerging evidence highlights the physiological relevance of L-glutamine uptake in immune and bone cells. Here, we present the cryo-EM structure of human y⁺LAT1/CD98hc at 3.4 Å resolution in an outward-open conformation bound to L-glutamine, revealing a non-canonical substrate-binding pose involving Cys320 in TM8. Combining docking and molecular dynamics simulations, and functional assays, we identify a Na+-binding tetrad (Asn49–Ser131–Gly323–Ser327) that underlies Na⁺-dependent transport of neutral amino acids. By contrast, cationic substrates such as L-arginine occupy the same locus with their positively charged side chain, effectively replacing the role of Na⁺ and enabling Na⁺-independent exchange. Mutagenesis and kinetic analyses support this mechanism and reveal a key role for Glu128 during transitions toward inward-facing conformations, providing structural insight into the transport cycle. Collectively, these findings establish how y⁺LAT1 integrates Na⁺ and substrate recognition to mediate the selective exchange of neutral and cationic amino acids. Here, cryo-EM, functional and computational studies reveal how the lysinuric protein intolerance transporter y⁺LAT1/CD98hc integrates Na⁺ and substrate recognition to mediate selective exchange of neutral and cationic amino acids.
Source: Nature Communications
Institutions: Consejo Superior de Investigaciones Científicas, Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Institut de Biologia Molecular de Barcelona, Parc Científic de Barcelona, Institut d'Investigació Biomédica de Bellvitge, Universitat de Barcelona, Universitat Autònoma de Barcelona, Barcelona Supercomputing Center, Spanish National Cancer Research Centre, Instituto de Salud Carlos III, Centre for Biomedical Network Research on Rare Diseases
Language: English
Subfield: Biochemistry
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $6,990
OpenAlex ID: W7214658732
